Bertolini Mark T 4

What Happened

• Mark T. Bertolini, CEO of Oscar Health (OSCR), disposed of a total of 1,206,310 shares in open-market sales on June 25–26, 2026. Transactions reported:
  • 597,942 shares at a weighted-average $28.60 — $17,101,141
  • 17,200 shares at $29.08 — $500,176
  • 441,373 shares at $29.11 — $12,848,368
  • 149,795 shares at $29.79 — $4,462,393
  • Total proceeds approximately $34.9 million.
• These were sales (code S) — typically routine dispositions rather than purchases that signal bullishness.

Key Details

• Dates: June 25–26, 2026. Filing date: June 29, 2026 (Form 4 accession 0001352552-26-000010).
• Price details: reported prices are weighted averages; the filing provides ranges for the multiple transactions (approx. $28.06–$30.17 across trades). The filer will supply per‑price breakdown on request.
• Purpose/footnotes: Sales were effected to satisfy tax-withholding obligations in connection with deferred settlement of performance stock units (PSUs) and time-based restricted stock units (RSUs) that vested April 3, 2026, and were executed pursuant to a Rule 10b5‑1 instruction (entered Nov 10, 2025; amended Mar 24, 2026).
• Shares owned after the transactions are not provided in the data you supplied.
• Timeliness: Form 4 was filed June 29, 2026; the filing appears consistent with Form 4 timing requirements for these transaction dates.

Context

• These sales were tax-withholding related and executed under a pre-existing 10b5‑1 plan — such transactions are typically administrative (to cover taxes on vested awards) rather than an investor signal of conviction.
• No option exercises, gifts, or purchases were reported in this filing.